Evidence map›Paper›PMID 34073356›Full record

ReviewAntioxidants (Basel, Switzerland)2021

Anticancer Effects of Lingonberry and Bilberry on Digestive Tract Cancers.

Tuulia Onali, Anne Kivimäki, Matti Mauramo, Tuula Salo, Riitta Korpela

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Journal of agricultural and food chemistry · 2024
    Article
  7. Experimental Studies on the Therapeutic Potential ofPlants (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Bilberry (Antioxidants (Basel, Switzerland) · 2021
    Article
  13. Mangiferin Inhibits Human Lung Adenocarcinoma by Suppressing MiR-27b and MiR-92a.Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tuulia OnaliDepartment of Oral and Maxillofacial Diseases, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
Anne KivimäkiDepartment of Oral and Maxillofacial Diseases, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
Matti MauramoDepartment of Pathology, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, 00014 Helsinki, Finland.ORCID 0000-0002-0107-4939
Tuula SaloDepartment of Oral and Maxillofacial Diseases, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
Riitta KorpelaMedical Nutrition Physiology, Department of Pharmacology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
University of Helsinki · FI

Funding

Helsinki University Central Hospital Research Funds NAJane ja Aatos Erkon Säätiö NASigrid Juséliuksen Säätiö NASyöpäsäätiö NA
6 · The paper itself

Abstract

Wild berries are part of traditional Nordic diets and are a rich source of phytochemicals, such as polyphenols. Various berry treatments have shown to interfere with cancer progression in vitro and in vivo. Here, we systematically reviewed the anticancer effects of two Nordic wild berries of the

Indexed as

anthocyaninbilberrycolorectal cancerinvasionlingonberrymigrationoral cancerphytochemicalpolyphenolproanthocyanidinproliferationtumorigenesis

Identifiers

PMID34073356
PMCPMC8228488
OpenAlexW3164520754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.